Retrospective Cohort Study
Copyright ©The Author(s) 2025.
World J Gastrointest Pharmacol Ther. Jun 5, 2025; 16(2): 103971
Published online Jun 5, 2025. doi: 10.4292/wjgpt.v16.i2.103971
Table 1 Characteristics of patients with cyclic vomiting, n (%)

Total number of patients (n = 32)
Female 22 (69)
Developmental delay/autism spectrum disorder 5 (16)
Started on prophylaxis medications16 (50)
Incidence of hypertension (Sato subset)3 (10)
History of migraines2 (7)
Identifiable food trigger0 (0)
Growth parameters
    Median weight-for-age z score-1.5 (range -3.8 to 2)
    Median BMI z score -1 (range -7.5 to 1.9)
    Weight z score < -2 12 (40)
    BMI z score < -212 (40)
    Height z score < -25 (16)
Table 2 A summary of worldwide pediatric cyclic vomiting syndrome cohort studies
Ref.
Cohort size
Mean age of onset
Overall sex ratio (male:female)
Concomitant incidence of migraine (%)
Mean frequency of attacks (before prophylaxis)
Response to prophylaxis
Abu-Arafeh et al[20]34 children 5 years 1:1218 episodes/yearNot described
Li et al[21]214 children6 years1:330Not describedNot described
Ertekin et al[22]24 children7 years1:225Not describedNot described
Haghighat et al[14]181 children5 years1:1206 episodes/yearNot described
Liao et al[12]24 children7 years2:1Not described2 episodes/year1 episode/year
Foreman et al[23]42 children4 years 1:1 412 episodes/yearNot described
Dipasquale et al[24]57 children8 years 1.3:1Not describedNot describedNot described
Singapore32 children 7 years 1:274 episodes/year1 episode/year